Yew Bio-Pharm Group, Inc.

No description available

5.02

Definitive information statement

No description available

General form for quarterly reports under Section 13 or 15(d)

No description available

General form for quarterly reports under Section 13 or 15(d)

5.02

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

5.02

General form for quarterly reports under Section 13 or 15(d)

Definitive information statement

No description available

No description available

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

8.01

Annual report pursuant to Section 13 or 15(d)

5.02

8.01

General form for quarterly reports under Section 13 or 15(d)

Definitive information statement

No description available

No description available

5.02

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

4.01,9.01

Notification of late filing of Form 10-Q

5.02

7.01,9.01

7.01,9.01

General form for quarterly reports under Section 13 or 15(d)

Definitive information statement

No description available

No description available

5.02

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

Annual report pursuant to Section 13 or 15(d)

Definitive information statement

No description available

General form for quarterly reports under Section 13 or 15(d)

No description available

7.01,9.01

2.02,9.01

Definitive information statement

No description available

No description available

2.03

No description available

Definitive information statement

1.01,2.03,9.01

1.01,2.03,7.01,9.01

1.01,7.01,9.01

No description available

No description available

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

Letter from the SEC

Registration (IPO) statement under Securities Act of 1933

Annual Report Scanned (Paper)

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

Letter from the SEC

Correspondence with the SEC

Amended Initial Registration Statement

Letter from the SEC

Registration (IPO) statement under Securities Act of 1933

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

Letter from the SEC

Correspondence with the SEC

No description available

No description available

No description available

Wu Xuehai

Tian Guoshuang

Liu Xiefeng

Shi Yongchun

Han Xingming

Qi Guifang

Qi Guifang

Qi Guifang

Wang Zhiguo

Han Xingming

Wang Zhiguo

Qi Guifang

Wang Zhiguo

Qi Guifang

WASSERMAN ADAM C

Han Xingming